Literature DB >> 3192195

Extensive necrosis in malignant lymphoma with granulomatous reaction mimicking tuberculosis.

P A Hall1, J Kingston, A G Stansfeld.   

Abstract

Epithelioid cell granulomas occur in association with a wide range of neoplasms but necrotizing granulomas mimicking tuberculosis are less well recognized. Two cases of high-grade malignant lymphoma of Burkitt type are presented which were associated with such a response. In both cases this caused difficulty in interpretation and in one led to delayed diagnosis. Regional lymph nodes were not involved by lymphoma but contained epithelioid cell granulomas in both cases. Features that suggested that the granulomatous reaction was related to the tumour included a close spatial relation, the reticulin pattern in the areas of necrosis and the immunohistochemical demonstration of lymphoid antigens in the necrotic debris. A diligent search for mycobacteria and other micro-organisms failed to reveal any infective cause. We suggest that the local granulomatous response is a reaction to the presence of necrotic and poorly viable tumour and the granulomas in nearby lymph nodes may be a response to tumour derived debris.

Entities:  

Mesh:

Year:  1988        PMID: 3192195     DOI: 10.1111/j.1365-2559.1988.tb02044.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  3 in total

1.  Necrobiotic palisading granulomas associated with breast carcinoma.

Authors:  J D Coyne
Journal:  J Clin Pathol       Date:  2005-12       Impact factor: 3.411

2.  Granulomatous Response with Breast Cancer: A Case Report.

Authors:  Bushra Siddiqui; Shahbaz Habib Faridi; Veena Maheshwari; Mohammad Aslam; Kafeel Akhter
Journal:  Iran J Pathol       Date:  2016

3.  Cervical lymphadenopathy--pitfalls of blind antitubercular treatment.

Authors:  Sudipta Pandit; Sabyasachi Choudhury; Anirban Das; Sibes Kumar Das; Soumya Bhattacharya
Journal:  J Health Popul Nutr       Date:  2014-03       Impact factor: 2.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.